WO1999048539A1 - Method for aroma delivery - Google Patents
Method for aroma delivery Download PDFInfo
- Publication number
- WO1999048539A1 WO1999048539A1 PCT/US1998/005582 US9805582W WO9948539A1 WO 1999048539 A1 WO1999048539 A1 WO 1999048539A1 US 9805582 W US9805582 W US 9805582W WO 9948539 A1 WO9948539 A1 WO 9948539A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ingredient
- aromatic
- aroma
- exothermic
- water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/015—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
- A61L9/02—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air by heating or combustion
Definitions
- the present invention relates generally to the field of methods of delivering aroma. More particularly, the present invention relates to methods for aroma delivery generated by an exothermic reaction.
- Aromatic volatile components have been widely used in variety of products, including pharmaceutical products.
- Certain types of aromatic volatile components e.g., menthol, eucalyptus oil, camphor, thymol
- menthol eucalyptus oil
- camphor eucalyptus oil
- thymol eucalyptus oil
- These pharmaceutical products are commonly used by inhaling aroma vapours along with water vapours to relieve blocked nose, cough, and other cold or allergy symptoms.
- the vapours are generated by using hot water or steam.
- aromatic volatile components have become increasingly popular. Consumers with mental stress often prefer to be in perfumed environments as a way to decrease stress. Due to their ability to induce relaxation and relief of mental stress, certain aromatic volatile components have become popular for treatment and therapy of such stress. These aromatic volatile components (e.g., cineol, jasmine, lavender oil) are known for providing fragranced environments in aroma therapy, as aromatic fragrance components.
- aromatic volatile components e.g., cineol, jasmine, lavender oil
- aroma therapy refers to a therapy which is for mental treatment, getting away from or releasing stress, and inducing relaxation, especially to ease mental stress.
- a conventional aroma therapy is by an inhalation of aroma vapours.
- Aroma is generated from the aromatic fragrance components by using hot water in combination with aromatic actives, or by heating a vessel, for example a pot or a plate, in which aromatic fragrance ingredients and water are placed. Consumers, however, tend to become frustrated with such methods of use, i.e., heating water for aroma vapours and/or steam inhalation, and with cleaning messy vessels due to oily or waxy bases used for aroma generation after the inhalation of aroma vapours.
- exothermic reactions have been previously used for the purpose of generating heat or increasing temperature.
- a variety of products using exothermic reactions are known, for example, in food products (e.g., self-heating meal modules, see Taub et al. U.S. Patent 5,517,981), pharmaceutical products (e.g., body warmers, see Sahara, U.S. Patent 5,220,909), or smoking articles (e.g., cigarette, see Potter et al. U.S. Patent 4,955,399).
- the present invention is directed to a method for aroma delivery comprising the step of applying water to a mixture of an effective amount of an aromatic ingredient, an exothermic ingredient, and a pH adjusting agent, thereby causing the temperature of the mixture to rise and resulting in volatilization of the aromatic ingredients.
- the method for aroma delivery of the present invention can be used in a variety of products in different industrial areas wherein conventional methods of delivering aroma have been previously used, which are, for example, heating or warming. These products are, for example, pharmaceuticals for medical treatment, and aroma therapy products for inducing relaxation and stress release by providing perfumed environments. Further, the method of delivering aroma of the present invention may be used for generating a certain toxin for pest control. Such methods are particularly useful for pharmaceutical products designed for ready inhalation of aromatic actives and fragrance compounds for treatment of cold or allergy symptoms (e.g., cold, blocked nose, and the like).
- the method of the present invention further may be used for products designed for body warming, for example, to warm the body to enable pain relief including heating or warming pads.
- the method may also be used to lessen the stress caused by such pains, at the time of treating the injury by warming the painful areas of the body.
- the method further can be useful for a kit product, for example, having two chambers, wherein one chamber contains a mixture of an aromatic ingredient, an exothermic ingredient, and a pH adjusting agent, and the other chamber contains water.
- a separator which is located between two chambers, is kept in place until the kit is used. When the separator is removed, water is combined with the mixed ingredients to generate heat, resulting in delivery of aroma.
- the present invention relates to a method for aroma delivery comprising the step of applying water to a mixture of an effective amount of an aromatic ingredient, an exothermic ingredient, and a pH adjusting agent, thereby causing the temperature of the mixture to rise, resulting in volatilization of the aromatic ingredient.
- the method of the present invention includes heat generation comprising a specified concentration of an exothermic ingredient which reacts with water to volatilize an aromatic ingredient.
- the temperature generated by the reaction of the exothermic ingredients with water is in the range of from about 40°C to about 100°C, more preferably from about 40°C to about 70°C. Without being bound by theory, it is believed that such temperature range is suitable for volatilizing aromatic ingredients including an aromatic active compound, and an aromatic fragrance compound.
- the method further includes steam generation which is caused by increasing temperature on the exothermic reaction with water, thereby aroma can be delivered with steam.
- steam generation which is caused by increasing temperature on the exothermic reaction with water, thereby aroma can be delivered with steam.
- Aromaatic ingredient herein refers to an ingredient which volatizes due to the temperature generated by the reaction of the exothermic ingredients with water, and delivers aroma to the user.
- the aromatic ingredients useful in the present invention include an aromatic active ingredient, an aromatic fragrance ingredient, and mixtures thereof.
- the aromatic ingredient may be provided in any form, for example, as an oil or as a water-oil emulsion.
- a kit product using the method of the present invention has two chambers, wherein one chamber contains an aromatic ingredient in emulsion, and another chamber contains an exothermic ingredient and a pH adjusting agent.
- Aromatic active ingredient herein means an ingredient which is specially used for a medical therapy.
- the aromatic active ingredient can include any ingredients which are conventionally used as actives for medical treatment, for example, various aromatic actives which may be volatile and useful for treatment of colds, allergy symptoms, and blocked nose in various over-the-counter products. These aromatic actives can be in solid or liquid form.
- Nonlimiting examples of the aromatic active ingredient include menthol, eucalyptus oil, camphor, thymol, turpentine oil, l-desoxyephedrine, bornyl acetate, and mixtures thereof.
- Aromaatic fragrance ingredient herein means an ingredient useful in aroma therapy for mental relaxation.
- Exemplary of the aromatic fragrance ingredients of the present invention include peppermint oil, spearmint oil, lavender oil, citronella oil, lemon oil, orange oil, sandalwood oil, and mixtures thereof.
- the aromatic active ingredient may further provide preferable fragrance in addition to the vapours for medical treatment purpose.
- Exothermic ingredient herein means an ingredient which is used for a reaction, called an exothermic reaction, to generate heat on reaction with water.
- the exothermic ingredients useful in the present invention can be any ingredients which are conventionally used for generating heat on reaction with water, and are available for use in pharmaceutical areas.
- the exothermic ingredients useful herein include a metal or a metal oxide.
- the metals of the present invention include, for example, magnesium and sodium, preferably magnesium.
- the preferred metal oxides herein are calcium oxide.
- Mechanisms of the exothermic reaction using metals differ from the reaction using metal oxides.
- the exothermic reaction of metal with water requires the presence of an acidic medium.
- the mechanism of the metal based exothermic reaction is that one mole of metal reacts with two moles of water in the presence of hydrogen ion, thereby one mole of metal hydroxide is derived, with the heat generation enabling volatilization of the aromatic ingredients.
- the following is an example of the exothermic reaction of the present invention using metal as the exothermic ingredient.
- the exothermic reaction (I) using metal with water derives a metal hydroxide with evolution of hydrogen gas.
- the hydrogen gas is evolved as bubbles and tends to give effervescence, leading to improve aesthetics. It is believed that the hydrogen gas may help the delivery of aroma and give a signal to the user as to the progress of the reaction of the exothermic ingredients with water.
- the quantity of water added based on the exothermic reaction (I) is from about 1 :20 to about 1 :100, preferably 1 :20 to 1 :50 to the ratio of metal by weight for generating the temperature appropriate to volatilize the aromatic ingredients.
- a composition using the method of delivering aroma including about 0.1 gm of metal is prepared and by adding about 5 ml (mgs) of water, a maximum temperature of about 68 degC. is generated for volatilizing the aromatic ingredients.
- the metal is of a high purity, and particularly when the aroma delivery in limited to occur using a large scale exothermic reaction (e.g., four times the amounts of metal and of water shown in the examples herein, as may be useful for providing aroma delivery in a room). It is believed that large scale exothermic reactions, particularly the reaction using magnesium, may cause off- odor or less odor reaction when the metal is of insufficient purity.
- a large scale exothermic reaction e.g., four times the amounts of metal and of water shown in the examples herein, as may be useful for providing aroma delivery in a room. It is believed that large scale exothermic reactions, particularly the reaction using magnesium, may cause off- odor or less odor reaction when the metal is of insufficient purity.
- metal oxide is the choice for the exothermic reaction to deliver aroma in the present invention
- one mole of water is needed for the reaction with one mole of the metal oxide.
- acids such as hydrogen ion for the exothermic reaction.
- one mole of a metal hydroxide is derived, with the appropriate temperature generation to volatilize the aromatic ingredients.
- the following is an example of the exothermic reaction using metal oxide.
- the exothermic reaction using metal oxide may include an effervescent agent.
- the quantity of metal oxide to water based on the exothermic reaction (II) is at least from about 1 :2 to about 1 :15 by weight, preferably from about 1 :2 to about 1 :5, for generating the temperature for volatilization of the aromatic ingredients.
- a composition using the method of delivering aroma including about 1gms of metal oxide is prepared and by adding about 5 ml (mgs) of water, a maximum temperature of about 67 degC. is generated for volatizing the aromatic ingredients.
- pH adjusting agent means a component which is useful for neutralization of the metal hydroxide derived by the exothermic reaction of the present invention described by reactions (I) and (II). It is recognized that these metal hydroxides derived from the exothermic ingredients with water tend to provide an undesirable alkaline pH condition, probably a pH of more than about 10. Generally, such pH condition is not safe. Therefore the pH adjusting agent is added to neutralize the metal hydroxides generated during the reaction. The following is a reaction for neutralization.
- the pH adjusting agent useful herein includes any of the acids used for conventional neutralizations.
- Exemplary of the pH adjusting agent herein are citric acid, oxalic acid, and tartaric acid.
- the pH adjusting agent can be added such that the conditions of the composition after aroma delivery are slightly acidic, preferably a pH of from about 3 to about 7.
- Total amount of the pH adjusting agents to the exothermic ingredients herein may be in the ratio from about 1 : 3 to about 1 : 6 by weight of the composition.
- the weight ratio of the metal to the pH adjusting agent is preferably at least about 1 : 6.
- the pH adjusting agent is at least about 1 : 3 by weight ratio.
- Additional ingredients The method of the present invention is useful for a variety of products or compositions in different areas as described above.
- compositions or products useful in this method can be formulated in a variety of forms depending upon the desired usage, for example, powder, granules, tablets, packed into bags (e.g., into a tea bag), or a kit comprising two or more chambers.
- the compositions useful in the method of the present invention may further comprise additional ingredients selected from the group consisting of a carrier, a effervescent agent, a binding agent, a coloring agent, a tableting aid, and mixtures thereof.
- the additional ingredients are preferably in a solid form to facilitate operating flowability and product stability.
- Additional ingredients must be of sufficiently high purity and of sufficiently low toxicity to obtain the desirable quality to aroma delivered.
- Additional ingredients other than described below that are useful for the present invention further include, for example, diluents such as glucose, mannitol and directly compressible sugar; stabilizing agents such as agar, pectin, gums and starches; antioxidants such as ascorbic acid and BHA; preservatives such as potassium sorbate and sodium benzoate, and the like; as well as other non-toxic compatible substances used in pharmaceutical formulation. 1. Effervescent agent
- reaction (II) does not provide bubbles, but sometimes it may be desirable to have bubbles, for example, for aesthetic purposes.
- "Effervescent agent” herein means any carbonate salt that provides bubbles when reacted with acid.
- the effervescence is evolved by the reaction of a carbonate source with an acidic source, for example, in the combination of a carbonate salt and a carboxylic acid. Any ingredients which would be useful conventionally as an effervescent agent in the pharmaceutical area may be acceptable herein.
- the effervescent agent of the present invention can be selected depending upon compatibility with other components, particularly the pH adjusting agent which reacts with the effervescent agent.
- the preferred effervescent agent herein is sodium hydrogencarbonate. The following is one embodiment of the reaction using sodium hydrogencarbonate with citric acids as acidic sources.
- the carbon dioxide is evolved by the reaction (IV) to provide effervescence.
- Carrier The composition useful in the method of the present invention, especially that which is in tablet form, may include a carrier.
- the carrier useful for the compositions herein can be any which is available and conventionally used in pharmaceutical compositions.
- the carrier can be selected depending upon the compatibility with all of the ingredients included as well as the desired characteristic of the composition.
- the carrier suitable herein is sugar.
- the carrier may be added in a variety of forms depending on the form of the composition, preferably the carrier in solid form. For example, when the composition is in tablet form, the carrier may be mixed with other ingredients such as the exothermic ingredient and the pH adjusting ingredient during granulation.
- the carrier is present at an effective level, preferably at a level of from about 10% to about 70% by weight.
- the carrier may be added to each of main ingredients such as the exothermic ingredient and the pH adjusting agent separately before mixing, to facilitate the process for making granules and/or tableting.
- the ratio of such ingredients to the carrier is about 50:50.
- Binding agent The composition useful in the method of the present invention may also include a binding agent. Inclusion of a binding agent is particularly useful to bind the components used for tablet forms of the composition. It is believed that insufficiencies in binding ability tend to cause compositions in tablet form, and especially those having a disc type shape, to break off into two pieces along the diameter during the manufacturing process. This splitting of the tablet is commonly referred to as "capping.” The levels and types of binding agent are selected depending upon compatibility with other components, and desired characteristic of the final product.
- binding agents examples include sugar, sugar alcohols, starches such as starch paste and pregelatinized starch, polyvinylpyrrolidone, cellulose derivatives, gelatin, gums, and mixtures thereof.
- the binding agent and the carrier may be made of the same material.
- the binding agent and the carrier may be altogether different. It is believed that the binding agent contributes to stability of the granules when added in the process of making granules.
- the binding agents may be present in an effective amount, preferably from about 0.1% to about 10% by weight, more preferably from about 0.5% to about 3%.
- Coloring agent may further include a coloring agent.
- the coloring agent may be present at an effective level, preferably from about 10 ppm to about 500 ppm, more preferably from about 20 ppm to about 250 ppm by weight. 10
- tableting aids can be added in order to facilitate forming the tablets.
- tabletteing aids refers to an ingredient that is added to the granules in small quantities to improve flowability to the granules, to reduce friction, and/or to ease removal of the tablets from the tableting machine.
- the tableting aids useful herein include, for example, magnesium stearate, stearic acid, aerosol, talc, and mixtures thereof.
- the tableting aid of the compositions of the present invention is preferably present in an amount sufficient to prevent the tablet from breaking into two pieces, preferably from about 0.1 % to about 8%, by weight of the tablet.
- Example I Example I Example I Example I Example IV Example V product type tea bag 1 tea bag 2 powder 1 powder 2 tablet calcium oxide 23.54 - 23.54 - - magnesium - 13.06 - 13.06 -
- Mg-granules containing 1:1 of magnesium and sugar Citric-granules containing 1 :1 of citric acid and sugar. 11
- Example 1 Pack 5gms mixture of Example 1 formulation and 2.04gms mixture of Example 2 formulation into Tea bag 1 and Tea bag 2, respectively for making tea bag type products.
- Example 3 and 4 are mixed for making powder type products (powder 1 and 2, respectively).
- Example 5 formulation 4.0mg mixture of Example 5 formulation is compressed into tablet form.
- Example I Use of tea bag 1 Put the tea bag 1 made by Example 1 formulation into a cup containing about 5ml of water, whereby heat is generated in the range from about 40 to about 70 degC, and inhale an aroma vapours delivered.
- Example II Use of tea bag 2 Put the tea bag 2 made by Example 2 formulation into a cup containing about 5ml of water, whereby heat is generated in the range from about 40 to about 70 degC, and inhale the aroma vapours delivered.
- tea bag 1 tea bag 2 mmiixxttuurree ppoorrttiioonnss iinn tteeaa bbaagg ((ggmm)) 5.0 2.04 water (ml) 5.0 5.0 temperature (°C) 40 - 70 40 - 70
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Fats And Perfumes (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11536055A JP2000510384A (en) | 1998-03-20 | 1998-03-20 | Method for fragrance release |
CA002324594A CA2324594A1 (en) | 1998-03-20 | 1998-03-20 | Method for aroma delivery |
AU67674/98A AU6767498A (en) | 1998-03-20 | 1998-03-20 | Method for aroma delivery |
BR9815750-7A BR9815750A (en) | 1998-03-20 | 1998-03-20 | Aroma release process |
PCT/US1998/005582 WO1999048539A1 (en) | 1998-03-20 | 1998-03-20 | Method for aroma delivery |
CN98813910.3A CN1294521A (en) | 1998-03-20 | 1998-03-20 | Method for aroma delivery |
EP98913022A EP1064029A1 (en) | 1998-03-20 | 1998-03-20 | Method for aroma delivery |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1998/005582 WO1999048539A1 (en) | 1998-03-20 | 1998-03-20 | Method for aroma delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999048539A1 true WO1999048539A1 (en) | 1999-09-30 |
Family
ID=22266652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/005582 WO1999048539A1 (en) | 1998-03-20 | 1998-03-20 | Method for aroma delivery |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1064029A1 (en) |
JP (1) | JP2000510384A (en) |
CN (1) | CN1294521A (en) |
AU (1) | AU6767498A (en) |
BR (1) | BR9815750A (en) |
CA (1) | CA2324594A1 (en) |
WO (1) | WO1999048539A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002068005A1 (en) * | 2001-02-26 | 2002-09-06 | The Procter & Gamble Company | Composition for aroma delivery with improved stability and reduced foaming |
WO2004103852A1 (en) * | 2003-05-19 | 2004-12-02 | Warmways Healthcare Holdings Plc | Heat-activated vapour generating device |
US6901609B2 (en) | 2001-01-15 | 2005-06-07 | The Procter & Gamble Company | Method of dispensing volatile and soluble substances and a device for use therein |
WO2008072109A2 (en) * | 2006-12-11 | 2008-06-19 | Kimberly-Clark Worldwide, Inc. | Methods for designing, making, and using a personal appliance for producing water vapor |
US9913924B2 (en) | 2016-05-25 | 2018-03-13 | S. C. Johnson & Son, Inc. | Dispensing device |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56167603A (en) * | 1980-05-30 | 1981-12-23 | Toyo Ink Mfg Co Ltd | Structural body for vaporizing agent by heating |
JPS59147076A (en) * | 1983-02-14 | 1984-08-23 | Kuraray Co Ltd | Heat-generating composition |
JPS60199813A (en) * | 1984-03-22 | 1985-10-09 | Taiji Tanigaki | Capsule type favorite material and drug |
JPS62153216A (en) * | 1985-12-26 | 1987-07-08 | Japan Ebian Kk | Perfumery heat-generating package |
JPH0224383A (en) * | 1988-07-14 | 1990-01-26 | Arao Sakurai | Pocketable chemical body warmer |
US4913168A (en) * | 1988-11-30 | 1990-04-03 | R. J. Reynolds Tobacco Company | Flavor delivery article |
WO1991007996A1 (en) * | 1989-12-04 | 1991-06-13 | The Clorox Company | Fragrance device and method, chemically or mechanically activated |
JPH06134025A (en) * | 1992-10-28 | 1994-05-17 | Sunstar Inc | Aromatic device and diffusion of aromatic using the same |
EP0695552A1 (en) * | 1994-08-05 | 1996-02-07 | F. Cube Co., Ltd. | Method of perfuming conveyances and perfuming article therefor |
JPH09220045A (en) * | 1995-11-20 | 1997-08-26 | Chiyuugai Chem Kogyo Kk | Device and method for vaporization |
-
1998
- 1998-03-20 EP EP98913022A patent/EP1064029A1/en not_active Withdrawn
- 1998-03-20 CN CN98813910.3A patent/CN1294521A/en active Pending
- 1998-03-20 WO PCT/US1998/005582 patent/WO1999048539A1/en not_active Application Discontinuation
- 1998-03-20 JP JP11536055A patent/JP2000510384A/en active Pending
- 1998-03-20 CA CA002324594A patent/CA2324594A1/en not_active Abandoned
- 1998-03-20 BR BR9815750-7A patent/BR9815750A/en not_active Application Discontinuation
- 1998-03-20 AU AU67674/98A patent/AU6767498A/en not_active Abandoned
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56167603A (en) * | 1980-05-30 | 1981-12-23 | Toyo Ink Mfg Co Ltd | Structural body for vaporizing agent by heating |
JPS59147076A (en) * | 1983-02-14 | 1984-08-23 | Kuraray Co Ltd | Heat-generating composition |
JPS60199813A (en) * | 1984-03-22 | 1985-10-09 | Taiji Tanigaki | Capsule type favorite material and drug |
JPS62153216A (en) * | 1985-12-26 | 1987-07-08 | Japan Ebian Kk | Perfumery heat-generating package |
JPH0224383A (en) * | 1988-07-14 | 1990-01-26 | Arao Sakurai | Pocketable chemical body warmer |
US4913168A (en) * | 1988-11-30 | 1990-04-03 | R. J. Reynolds Tobacco Company | Flavor delivery article |
WO1991007996A1 (en) * | 1989-12-04 | 1991-06-13 | The Clorox Company | Fragrance device and method, chemically or mechanically activated |
JPH06134025A (en) * | 1992-10-28 | 1994-05-17 | Sunstar Inc | Aromatic device and diffusion of aromatic using the same |
EP0695552A1 (en) * | 1994-08-05 | 1996-02-07 | F. Cube Co., Ltd. | Method of perfuming conveyances and perfuming article therefor |
JPH09220045A (en) * | 1995-11-20 | 1997-08-26 | Chiyuugai Chem Kogyo Kk | Device and method for vaporization |
Non-Patent Citations (7)
Title |
---|
DATABASE WPI Section Ch Week 8206, Derwent World Patents Index; Class C03, AN 82-10634E, XP002084951 * |
DATABASE WPI Section Ch Week 8440, Derwent World Patents Index; Class A97, AN 84-246116, XP002084952 * |
DATABASE WPI Section Ch Week 8547, Derwent World Patents Index; Class B07, AN 85-292289, XP002084953 * |
DATABASE WPI Section Ch Week 8733, Derwent World Patents Index; Class A96, AN 87-230747, XP002084950 * |
DATABASE WPI Section Ch Week 9010, Derwent World Patents Index; Class B07, AN 90-071346, XP002084954 * |
DATABASE WPI Section Ch Week 9744, Derwent World Patents Index; Class C07, AN 97-474271, XP002084949 * |
PATENT ABSTRACTS OF JAPAN vol. 018, no. 433 (C - 1237) 12 August 1994 (1994-08-12) * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6901609B2 (en) | 2001-01-15 | 2005-06-07 | The Procter & Gamble Company | Method of dispensing volatile and soluble substances and a device for use therein |
US6944889B2 (en) | 2001-01-15 | 2005-09-20 | The Procter & Gamble Company | Method of dispensing volatile and soluble substances and a device for use therein |
WO2002068005A1 (en) * | 2001-02-26 | 2002-09-06 | The Procter & Gamble Company | Composition for aroma delivery with improved stability and reduced foaming |
WO2004103852A1 (en) * | 2003-05-19 | 2004-12-02 | Warmways Healthcare Holdings Plc | Heat-activated vapour generating device |
WO2008072109A2 (en) * | 2006-12-11 | 2008-06-19 | Kimberly-Clark Worldwide, Inc. | Methods for designing, making, and using a personal appliance for producing water vapor |
WO2008072109A3 (en) * | 2006-12-11 | 2008-09-18 | Kimberly Clark Co | Methods for designing, making, and using a personal appliance for producing water vapor |
US9913924B2 (en) | 2016-05-25 | 2018-03-13 | S. C. Johnson & Son, Inc. | Dispensing device |
Also Published As
Publication number | Publication date |
---|---|
BR9815750A (en) | 2001-10-09 |
JP2000510384A (en) | 2000-08-15 |
EP1064029A1 (en) | 2001-01-03 |
CN1294521A (en) | 2001-05-09 |
AU6767498A (en) | 1999-10-18 |
CA2324594A1 (en) | 1999-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1063960A1 (en) | Composition for aroma delivery | |
US5993854A (en) | Exothermic effervescent composition for improved fragrance dispersion | |
JP2007536255A (en) | Compositions for inhalation therapy and methods of use | |
JPS61254170A (en) | Nicotine preparation | |
EP1064029A1 (en) | Method for aroma delivery | |
KR20220162136A (en) | Compositions containing menthol | |
JP6839181B2 (en) | Tobacco filling for non-combustible heated smoking articles | |
MXPA04004907A (en) | Acetaminophen compositions. | |
US5891427A (en) | Vitaminized air freshner and room deodorizer | |
DE69928011T2 (en) | EXOTHERMIC BRUSH PREPARATION FOR THE IMPROVED DISPERSION OF AROMAS | |
WO2010113144A2 (en) | A tablet composition | |
MXPA00009182A (en) | Method for aroma delivery | |
MXPA00009193A (en) | Composition for aroma delivery | |
JP7335758B2 (en) | Effervescent solid bath agent | |
JP2013139396A (en) | Solid bathing agent | |
JP5306159B2 (en) | Method for imparting mental enhancement effect in fragrance composition | |
JP5576621B2 (en) | Body odor suppressor for internal use | |
JP7382766B2 (en) | Foaming solid bath additive | |
JP2008162923A (en) | Method for producing bathing agent | |
KR20180135021A (en) | Tobacco packing for non-smoking small heating smoking articles | |
WO2022210842A1 (en) | Oral pouch product | |
JP2014183774A (en) | Method for adjusting persistence of deodorizing effect of chewing gum composition after chewed, and the chewing gum composition | |
WO2024097549A1 (en) | Composition and method for controlled human nicotine absorption without ph adjusters | |
JPS63139118A (en) | Intraoral cleaning agent | |
GB2352161A (en) | Chewing gum containing caffeine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 98813910.3 Country of ref document: CN |
|
ENP | Entry into the national phase |
Ref document number: 1999 536055 Country of ref document: JP Kind code of ref document: A |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09646289 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2324594 Country of ref document: CA Ref document number: 2324594 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2000/009182 Country of ref document: MX |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998913022 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1998913022 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998913022 Country of ref document: EP |